<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Mavoglurant</id>
	<title>Mavoglurant - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Mavoglurant"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Mavoglurant&amp;action=history"/>
	<updated>2026-04-27T14:43:12Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Mavoglurant&amp;diff=5895797&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Mavoglurant&amp;diff=5895797&amp;oldid=prev"/>
		<updated>2024-06-10T13:45:40Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Mavoglurant.svg|thumb|Mavoglurant]] &amp;#039;&amp;#039;&amp;#039;Mavoglurant&amp;#039;&amp;#039;&amp;#039; (also known as &amp;#039;&amp;#039;&amp;#039;AFQ056&amp;#039;&amp;#039;&amp;#039;) is a drug that acts as a selective antagonist for the [[metabotropic glutamate receptor 5]] (mGluR5). It has been investigated for its potential therapeutic effects in various [[neurological disorders]] and [[psychiatric conditions]].&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
Mavoglurant works by inhibiting the activity of mGluR5, a receptor that plays a crucial role in the modulation of [[glutamate]], the primary excitatory neurotransmitter in the [[central nervous system]]. By blocking mGluR5, mavoglurant can potentially reduce excessive glutamate activity, which is implicated in several neurological and psychiatric disorders.&lt;br /&gt;
&lt;br /&gt;
==Therapeutic Uses==&lt;br /&gt;
Mavoglurant has been studied for its potential use in treating conditions such as [[Fragile X syndrome]], [[Parkinson&amp;#039;s disease]], and [[anxiety disorders]]. &lt;br /&gt;
&lt;br /&gt;
===Fragile X Syndrome===&lt;br /&gt;
Fragile X syndrome is a genetic disorder that causes intellectual disability, behavioral and learning challenges, and various physical characteristics. Mavoglurant has been investigated as a treatment to alleviate some of the symptoms associated with this condition by modulating glutamate signaling.&lt;br /&gt;
&lt;br /&gt;
===Parkinson&amp;#039;s Disease===&lt;br /&gt;
In [[Parkinson&amp;#039;s disease]], mavoglurant has been explored for its potential to manage [[levodopa]]-induced dyskinesia, a common side effect of long-term levodopa therapy. By inhibiting mGluR5, mavoglurant may help reduce these involuntary movements.&lt;br /&gt;
&lt;br /&gt;
===Anxiety Disorders===&lt;br /&gt;
Mavoglurant has also been studied for its anxiolytic effects, given the role of glutamate in anxiety and stress responses. By modulating mGluR5 activity, mavoglurant may offer a new approach to treating anxiety disorders.&lt;br /&gt;
&lt;br /&gt;
==Clinical Trials==&lt;br /&gt;
Several clinical trials have been conducted to evaluate the efficacy and safety of mavoglurant in various conditions. While some studies have shown promising results, others have not demonstrated significant benefits, leading to ongoing research and development.&lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
Common side effects of mavoglurant may include [[headache]], [[dizziness]], and [[nausea]]. As with any medication, the risk of side effects must be weighed against the potential therapeutic benefits.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[Metabotropic glutamate receptor]]&lt;br /&gt;
* [[Glutamate]]&lt;br /&gt;
* [[Fragile X syndrome]]&lt;br /&gt;
* [[Parkinson&amp;#039;s disease]]&lt;br /&gt;
* [[Anxiety disorders]]&lt;br /&gt;
&lt;br /&gt;
==Related Pages==&lt;br /&gt;
* [[Metabotropic glutamate receptor 5]]&lt;br /&gt;
* [[Glutamate receptor]]&lt;br /&gt;
* [[Neurological disorder]]&lt;br /&gt;
* [[Psychiatric condition]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Drugs]]&lt;br /&gt;
[[Category:Neurology]]&lt;br /&gt;
[[Category:Psychiatry]]&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>